Logo image of CVR

CHICAGO RIVET & MACHINE CO (CVR) Stock Fundamental Analysis

NYSEARCA:CVR - NYSE Arca - US1680881026 - Common Stock - Currency: USD

14.79  -0.15 (-1%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CVR. CVR was compared to 129 industry peers in the Machinery industry. CVR has a great financial health rating, but its profitability evaluates not so good. CVR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CVR has reported negative net income.
CVR had a positive operating cash flow in the past year.
Of the past 5 years CVR 4 years were profitable.
In multiple years CVR reported negative operating cash flow during the last 5 years.
CVR Yearly Net Income VS EBIT VS OCF VS FCFCVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

1.2 Ratios

CVR has a Return On Assets of -13.43%. This is amonst the worse of the industry: CVR underperforms 81.60% of its industry peers.
CVR has a Return On Equity of -14.98%. This is in the lower half of the industry: CVR underperforms 76.00% of its industry peers.
Industry RankSector Rank
ROA -13.43%
ROE -14.98%
ROIC N/A
ROA(3y)-1.26%
ROA(5y)-0.38%
ROE(3y)-1.28%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
CVR Yearly ROA, ROE, ROICCVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1.3 Margins

The Gross Margin of CVR (6.96%) is worse than 92.80% of its industry peers.
CVR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CVR Yearly Profit, Operating, Gross MarginsCVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

9

2. Health

2.1 Basic Checks

CVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CVR remains at a similar level compared to 1 year ago.
The number of shares outstanding for CVR remains at a similar level compared to 5 years ago.
There is no outstanding debt for CVR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CVR Yearly Shares OutstandingCVR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K
CVR Yearly Total Debt VS Total AssetsCVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

An Altman-Z score of 5.79 indicates that CVR is not in any danger for bankruptcy at the moment.
The Altman-Z score of CVR (5.79) is better than 80.80% of its industry peers.
CVR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.79
ROIC/WACCN/A
WACC10.6%
CVR Yearly LT Debt VS Equity VS FCFCVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 6.02 indicates that CVR has no problem at all paying its short term obligations.
CVR has a better Current ratio (6.02) than 93.60% of its industry peers.
CVR has a Quick Ratio of 3.13. This indicates that CVR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.13, CVR belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.02
Quick Ratio 3.13
CVR Yearly Current Assets VS Current LiabilitesCVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

0

3. Growth

3.1 Past

CVR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.01%, which is quite good.
CVR shows a decrease in Revenue. In the last year, the revenue decreased by -6.08%.
CVR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.25% yearly.
EPS 1Y (TTM)15.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50.06%
Revenue 1Y (TTM)-6.08%
Revenue growth 3Y4.52%
Revenue growth 5Y-3.25%
Sales Q2Q%-12.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CVR Yearly Revenue VS EstimatesCVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CVR Yearly EPS VS EstimatesCVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVR Price Earnings VS Forward Price EarningsCVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVR Per share dataCVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.80%, CVR is not a good candidate for dividend investing.
In the last 3 months the price of CVR has falen by -20.01%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
CVR's Dividend Yield is comparable with the industry average which is at 1.65.
With a Dividend Yield of 0.80, CVR pays less dividend than the S&P500 average, which is at 2.27.
Industry RankSector Rank
Dividend Yield 0.8%

5.2 History

The dividend of CVR decreases each year by -10.90%.
CVR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-10.9%
Div Incr Years0
Div Non Decr Years0
CVR Yearly Dividends per shareCVR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

CVR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-10.9%
EPS Next 2YN/A
EPS Next 3YN/A
CVR Yearly Income VS Free CF VS DividendCVR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M

CHICAGO RIVET & MACHINE CO

NYSEARCA:CVR (2/21/2025, 8:11:25 PM)

14.79

-0.15 (-1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)03-26 2025-03-26
Inst Owners19.67%
Inst Owner Change-99.11%
Ins Owners6.54%
Ins Owner Change0%
Market Cap14.35M
Analysts0
Price TargetN/A
Short Float %0.95%
Short Ratio3.21
Dividend
Industry RankSector Rank
Dividend Yield 0.8%
Yearly Dividend0.64
Dividend Growth(5Y)-10.9%
DP-10.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF 20.26
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-3.67
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)0.73
OCFY4.94%
SpS30.58
BVpS24.41
TBVpS24.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.43%
ROE -14.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.96%
FCFM N/A
ROA(3y)-1.26%
ROA(5y)-0.38%
ROE(3y)-1.28%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.26%
Cap/Sales 2.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.02
Quick Ratio 3.13
Altman-Z 5.79
F-Score6
WACC10.6%
ROIC/WACCN/A
Cap/Depr(3y)70.41%
Cap/Depr(5y)80.57%
Cap/Sales(3y)2.76%
Cap/Sales(5y)3.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.08%
Revenue growth 3Y4.52%
Revenue growth 5Y-3.25%
Sales Q2Q%-12.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y174.12%
OCF growth 3YN/A
OCF growth 5YN/A